127 related articles for article (PubMed ID: 21042036)
1. Inhibition of ankyrin-B expression reduces growth and invasion of human pancreatic ductal adenocarcinoma.
Chen Y; Löhr M; Jesnowski R
Pancreatology; 2010; 10(5):586-96. PubMed ID: 21042036
[TBL] [Abstract][Full Text] [Related]
2. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
3. Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells.
Dumartin L; Quemener C; Laklai H; Herbert J; Bicknell R; Bousquet C; Pyronnet S; Castronovo V; Schilling MK; Bikfalvi A; Hagedorn M
Gastroenterology; 2010 Apr; 138(4):1595-606, 1606.e1-8. PubMed ID: 20080097
[TBL] [Abstract][Full Text] [Related]
4. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
[TBL] [Abstract][Full Text] [Related]
6. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression.
Kitaura Y; Chikazawa N; Tasaka T; Nakano K; Tanaka M; Onishi H; Katano M
Pancreas; 2011 Oct; 40(7):1034-42. PubMed ID: 21697762
[TBL] [Abstract][Full Text] [Related]
8. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
[TBL] [Abstract][Full Text] [Related]
9. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma.
Xue X; Lu Z; Tang D; Yao J; An Y; Wu J; Li Q; Gao W; Xu Z; Qian Z; Dai C; Wei J; Miao Y; Jiang K
Pancreas; 2011 Aug; 40(6):832-9. PubMed ID: 21747316
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
11. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
13. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
14. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
Egberts JH; Cloosters V; Noack A; Schniewind B; Thon L; Klose S; Kettler B; von Forstner C; Kneitz C; Tepel J; Adam D; Wajant H; Kalthoff H; Trauzold A
Cancer Res; 2008 Mar; 68(5):1443-50. PubMed ID: 18316608
[TBL] [Abstract][Full Text] [Related]
16. Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway.
Ketterer K; Kong B; Frank D; Giese NA; Bauer A; Hoheisel J; Korc M; Kleeff J; Michalski CW; Friess H
Cancer Lett; 2009 May; 277(1):72-81. PubMed ID: 19118941
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
[TBL] [Abstract][Full Text] [Related]
18. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
Fleming JB; Shen GL; Holloway SE; Davis M; Brekken RA
Mol Cancer Res; 2005 Jul; 3(7):413-23. PubMed ID: 16046552
[TBL] [Abstract][Full Text] [Related]
19. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
Wang JG; Li NN; Li HN; Cui L; Wang P
Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]